Type 2 Diabetes Study

Now Open in Savannah, GA, and Binghamton, NY

While diet and exercise can help manage the symptoms of type 2 diabetes (T2D), there is no cure. People with T2D either resist the effects of insulin, or their bodies don’t produce enough of the hormone to maintain normal levels of glucose. Meridian is now conducting a phase 3 clinical study is for an investigational diabetes medication.

Eligible participants…

  • Must be age 18 to 75
  • Have been diagnosed with T2D at least 6 months prior to screening
  • Must have A1C ≥7.5% but ≤11.0% at screening
  • Must be on a stable dose of at least two and up to three of the following oral glucose-lowering agents for at least the past 3 months: Metformin, DPP-4 inhibitor, SGLT-2 inhibitor, Thiazolidinedione, Insulin secretagogue, Oral GLP-1 receptor agonists
  • Must have a body mass index (BMI) of 25-40
  • Must have a stable weight (no more than 11 lbs. gained or lost in the last 3 months)
  • Will receive compensation for study-related time
  • Do not need insurance to join this study

For more information, complete the form on this page. After you submit your information, a Meridian enrollment specialist will call you to talk about the study. There is no obligation to join — you can decide if the study is right for you.

You can also talk to a Meridian enrollment specialist about this study by calling (912) 623-2240.

Submit your information

Expect Excellence icon - supporting research since 1999

Founded in 1999 in Omaha, NE, Meridian studies the safety and effectiveness of new medicines, devices, and treatments. Its mission is to enrich lives by providing quality, compassionate care to patients and unparalleled clinical research services. Clinical studies help scientists develop life-changing medicines, but it starts with you — participation makes it all possible. For more than 20 years, thousands of patients have trusted Meridian because of our focus on creating a positive patient experience.